Improved spillover correction model to quantify myocardial blood flow by 11C-acetate PET: comparison with 15O-H2O PET

Annals of Nuclear Medicine

Volumn 29, Issue 1, 2015, Pages 15-20

  Mori, Yuki ^a   Manabe, Osamu ^a   Naya, Masanao ^a   Tomiyama, Yuuki ^a   Yoshinaga, Keiichiro ^a   Magota, Keiichi ^a   Oyama Manabe, Noriko ^b   Hirata, Kenji ^a   Tsutsui, Hiroyuki ^a   Tamaki, Nagara ^a   Katoh, Chietsugu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

11C acetate; 15O H2O; PET; Regional myocardial blood flow; Spillover correction

Indexed keywords

ACETIC ACID C 11; WATER O 15; ACETIC ACID DERIVATIVE; CARBON; OXYGEN; RADIOPHARMACEUTICAL AGENT; WATER;

ADULT; ARTICLE; CARDIAC IMAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BIOLOGICAL MODEL; CORONARY ARTERY BLOOD FLOW; MIDDLE AGED; PHYSIOLOGY; PILOT STUDY; PROCEDURES; SIGNAL PROCESSING; VALIDATION STUDY;

ACETATES; CARBON RADIOISOTOPES; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; OXYGEN RADIOISOTOPES; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SIGNAL PROCESSING, COMPUTER-ASSISTED; WATER;

EID: 84926005495     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-014-0904-z     Document Type: Article

References (23)

1. Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med. 1989;30:187–93.
2. Sun KT, Yeatman LA, Buxton DB, Chen K, Johnson JA, Huang SC, et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med. 1998;39:272–80.
3. 15O-water and 1-11C-acetate in rats with small-animal PET. J Nucl Med. 2006;47:477–85.
4. Katoh C, Yoshinaga K, Klein R, Kasai K, Tomiyama Y, Manabe O, et al. Quantification of regional myocardial blood flow estimation with three-dimensional dynamic rubidium-82 PET and modified spillover correction model. J Nucl Cardiol. 2012;19:763–74.
5. Yoshinaga K, Tomiyama Y, Suzuki E, Tamaki N. Myocardial blood flow quantification using positron-emission tomography. Circ J. 2013;77:1662–71.
6. Wu YW, Naya M, Tsukamoto T, Komatsu H, Morita K, Yoshinaga K, et al. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET. Circ J. 2008;72:786–92.
7. 15O-water with PET. J Nucl Med. 2004;45:1908–16.
8. van den Hoff J, Burchert W, Borner AR, Fricke H, Kuhnel G, Meyer GJ, et al. [1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med. 2001;42:1174–82.
9. Buck A, Wolpers HG, Hutchins GD, Savas V, Mangner TJ, Nguyen N, et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med. 1991;32:1950–7.
10. 11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2010;17:264–75.
11. Manabe O, Yoshinaga K, Katoh C, Naya M, deKemp RA, Tamaki N. Repeatability of rest and hyperemic myocardial blood flow measurements with 82Rb dynamic PET. J Nucl Med. 2009;50:68–71.
12. Herrero P, Markham J, Shelton ME, Bergmann SR. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res. 1992;70:496–507.
13. Tsukamoto T, Morita K, Naya M, Katoh C, Inubushi M, Kuge Y, et al. Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease. Eur J Nucl Med. 2006;33:1150–6.
14. Chan SY, Brunken RC, Phelps ME, Schelbert HR. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med. 1991;32:665–72.
15. Sun KT, Chen K, Huang SC, Buxton DB, Hansen HW, Kim AS, et al. Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. J Nucl Med. 1997;38:459–66.
16. Burger C, Buck A. Requirements and implementation of a flexible kinetic modeling tool. J Nucl Med. 1997;38:1818–23.
17. Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med. 2001;28:651–68.
18. Naya M, Murthy VL, Blankstein R, Sitek A, Hainer J, Foster C, et al. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011;58:1807–16.
19. Goldstein RA, Kirkeeide RL, Demer LL, Merhige M, Nishikawa A, Smalling RW, et al. Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man. J Clin Invest. 1987;79:1473–8.
20. Yoshinaga K, Katoh C, Noriyasu K, Iwado Y, Furuyama H, Ito Y, et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J Nucl Cardiol. 2003;10:275–83.
21. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med. 1984;310:819–24.
22. Naya M, Di Carli MF. Myocardial perfusion PET/CT to evaluate known and suspected coronary artery disease. Q J Nucl Med Mol Imaging. 2010;54:145–56.
23. Siegrist PT, Gaemperli O, Koepfli P, Schepis T, Namdar M, Valenta I, et al. Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET. J Nucl Med. 2006;47:1420–6.